An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world.
Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.
Table of Contents
|2 A Global Perspective on Drug-Resistant Tuberculosis||9-28|
|3 Drug-Resistant Tuberculosis in the Russian Federation||29-36|
|4 Transmission and Infection Control of Drug-Resistant TB||37-48|
|5 Diagnosis of Drug-Resistant TB||49-62|
|6 Treatment of Drug-Resistant TB||63-74|
|7 TB and Drug-Resistant TB in Vulnerable Populations||75-86|
|8 The Second-Line Drug Supply Chain||87-94|
|9 The Development of New TB Diagnostics and Drugs||95-100|
|10 Convergence of Science and Policy to Create a Call for Action||101-108|
|Appendix A: Agenda||113-120|
|Appendix B: Summary of a Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Held May 2425, 2010, Moscow, Russian Federation||121-122|
|Appendix C: Participant Biographies||123-140|
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.